Literature DB >> 29391996

Human Immunodeficiency Virus (HIV) Positive Case with Squamous Cell Larynx Cancer: Difficulties in the Choice of Treatment.

Özlem Ünsal1, Bilge Türk1, Meltem Akpınar1, Mustafa Bağlı1, Berna Uslu Coşkun1.   

Abstract

Squamous cell carcinoma of the larynx is rarely encountered in HIV (human immunodeficiency virus)-positive patients compared with HIV-associated malignancies. Standard protocols are absent for the management of laryngeal carcinoma in HIV-positive patients. HIV infection-associated immune suppression increases the mortality and morbidity of laryngeal carcinoma treatment. In the management of laryngeal carcinoma in HIV-positive patients, beside the clinical staging, the detection of CD4+ cell count is important. Regular antiretroviral treatment may have favorable effects in the management of laryngeal carcinoma. The treatment modality in the presented HIV-positive case with the diagnosis of laryngeal cancer was determined with a multidisciplinary approach.

Entities:  

Keywords:  HIV; Laryngeal cancer; immunodeficiency; retrovirus; treatment

Year:  2015        PMID: 29391996      PMCID: PMC5782918          DOI: 10.5152/tao.2015.839

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  12 in total

1.  Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.

Authors:  B Singh; M Bhaya; M Zimbler; J Stern; J T Roland; R M Rosenfeld; G Har-El; F E Lucente
Journal:  Head Neck       Date:  1998-01       Impact factor: 3.147

2.  The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.

Authors:  R Hoffman; M L Welton; B Klencke; V Weinberg; R Krieg
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

3.  Alterations in head and neck cancer occurring in HIV-infected patients--results of a pilot, longitudinal, prospective study.

Authors:  B Singh; S Sabin; O Rofim; A Shaha; G Har-El; F E Lucente
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

4.  Cancer incidence in New York State acquired immunodeficiency syndrome patients.

Authors:  B Gallagher; Z Wang; M J Schymura; A Kahn; E J Fordyce
Journal:  Am J Epidemiol       Date:  2001-09-15       Impact factor: 4.897

5.  Squamous cell carcinoma of the larynx in HIV-positive patients: difficulties in diagnosis and management.

Authors:  E J S M Blenke; W A Clement; J M Andrews; E Scanlon; G A Vernham
Journal:  Dysphagia       Date:  2006-11-01       Impact factor: 3.438

6.  Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation.

Authors:  E B Watkins; P Findlay; E Gelmann; H C Lane; A Zabell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-09       Impact factor: 7.038

7.  Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus.

Authors:  Patricia Nguyen; Kirsten Vin-Christian; Michael E Ming; Timothy Berger
Journal:  Arch Dermatol       Date:  2002-06

8.  Wound healing after implant surgery in HIV-positive patients.

Authors:  W J Harrison; C P Lewis; C B D Lavy
Journal:  J Bone Joint Surg Br       Date:  2002-08

9.  Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection.

Authors:  B Singh; A N Balwally; A R Shaha; R M Rosenfeld; G Har-El; F E Lucente
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-06

10.  CD4 Count and Anti Retroviral Therapy for HIV Positive Patients With Cancer in Nigeria -A Pilot Study.

Authors:  Atara I Ntekim; Ayo M Folasire
Journal:  Clin Med Insights Oncol       Date:  2010-07-07
View more
  1 in total

1.  Impact of human immunodeficiency virus status on laryngeal cancer survival and locoregional control.

Authors:  Samuel Franklin Weinreb; Krzysztof Piersiala; Shumon Ian Dhar; Alexander T Hillel; Lee Akst; Simon R A Best
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.